While WNT5A/ROR2 signaling acts tumor suppressive in hepatocellular carcinoma [30], gastric carcinoma [31], and myelogenous leukemia [32], it enhances proliferation of chronic lymphocytic leukemia [21]. Here, WNT5A is linked to gastric carcinoma.